NEW YORK (TheStreet) -- Athenahealth  (ATHN) released new data reporting more than 1,600 people requested a Zika virus screening, CNBC's Andrew Ross Sorkin said on "Squawk Alley" Friday. 

The San Diego-based healthcare company has partnered with authorities in Miami to fight the virus before it spreads, he said. 

In order to get the test, patients must to go to the public health commission. The CDC is the reference lab that will fax the results over to the patient in 2-7 days, Athenahealth CEO Jonathan Bush told CNBC

Athenahealth found 2,000 men and women who are risk profile. The company is driving in those people for the test and will be surveilling the results.

The results have all been negative so far but are have over 300 tests are now being done per day.

Shares of Athenahealth are trading higher this afternoon. 

Separately, TheStreet Ratings team set this stock as a "hold" with a ratings score of C. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and unimpressive growth in net income.

TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author. TheStreet Ratings has this to say about the recommendation:

You can view the full analysis from the report here: ATHN